Entities / Company
Myriad Genetics.
American biotechnology company
- Reports this week
- 2
- Active events
- 2
- Connections
- 71
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Earlier this month
-
A committee holds a hearing regarding challenges facing various industries, including testimony from experts on the impact of Supreme Court decisions on Myriad Genetics.Some support2 reports
-
MarketBeat is reporting on analyst recommendations and consensus target prices for small-cap healthcare companies Myriad Genetics and Applied DNA Sciences.Some support2 reports
One to three months ago
-
Several companies, including Guardant Health and Myriad Genetics, are competing in the liquid biopsy market.Some support1 report1 development inside
-
Myriad Genetics has a law firm based in New York City.Some support1 report
-
Myriad Genetics and Dyadic International are both small-cap healthcare companies that develop and sell products in the United States.Some support1 report
-
Ben Wheeler was promoted to Chief Financial Officer (CFO) at Myriad Genetics on August 18, 2025.Some support3 reports
-
Carrie Wheeler provided financial commentary regarding the results of Myriad Genetics on July 30, 2026.Some support1 report
Gone quiet
No new reports in 90+ days-
Sera and Myriad Genetics are appointing a board of directors to guide the company, both operating in diagnostics and life sciences.Some support1 report
-
Myriad Genetics and Palo Alto Networks are mentioned as high-flying stocks, and Nir Zuk is noted as the founder of Palo Alto Networks.Speculative1 report
-
Myriad Genetics received certification based on employee feedback.Some support1 report
-
Major diagnostic companies, including Bio-Rad, Quest Diagnostics, and Myriad Genetics, are driving market growth.Some support1 report1 development inside
-
UnitedHealth Group reported poor earnings on July 30, 2025.Some support2 reports
-
UnitedHealth Group, Myriad Genetics, and NeoGenomics are involved in a situation concerning the cancer diagnostics space and weaknesses in the broader healthcare sector.Some support1 report2 developments inside
-
Myriad Genetics, Biogen, Moderna, and Microsoft are discussed as peers in the therapeutics segment and are mentioned in thematic investing contexts.Some support1 report1 development inside
-
Myriad Genetics shares underperformed the market index on August 6, 2025, while operating in the biomedical and genetics industry and tracking earnings estimate revisions.Some support2 reports
-
Greg Abram, who previously held leadership roles at Myriad Genetics, was welcomed to the RxPreferred Benefits team along with Keith, announced in Nashville on August 12, 2025.Some support1 report
-
Sam Raha highlighted operational execution and workflow improvements at Myriad Genetics on August 13, 2025.Some support2 reports
-
TD Cowen analyst inquired about growth contributions regarding Myriad Genetics.Well supported3 reports
-
Personal health and wellness is identified as a secular tailwind for the industry.Some support1 report
-
Angle and Myriad Genetics are collaborating, with Angle providing CTCs from tissue tests for Myriad's molecular analysis, aiming to extend to blood samples.Some support1 report
-
Bio-Techne and Myriad Genetics are identified as key players in the biomarkers industry, while the American Cancer Society provides prostate cancer prevalence statistics.Some support1 report
-
Myriad's MRD test was studied by Chad Tang.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Myriad Genetics this week
News at the entities that move Myriad Genetics most-
TD Cowen OperationalTD Cowen reaffirmed a buy rating while Cantor Fitzgerald downgraded monday.com Ltd. on October 6, 2026.Moves Myriad Genetics
-
supreme court TransactionalYSRCP filed petitions across the High Court and approached courts in Bengaluru to stall elections.Moves Myriad Genetics
-
MarketBeat Mentioned togetherMarketBeat reported analyst recommendations for small-cap technology companies Energous Corporation and Magnachip Semiconductor.Moves Myriad Genetics
-
Applied DNA Sciences OperationalApplied DNA Sciences and Bolt Biotherapeutics, both small-cap healthcare companies, are being compared on their stock price volatility relative to the S&P 500.Moves Myriad Genetics
-
New York City Shared contextNYC pension funds are investing in Israel bonds, leading to debate and advocacy from figures like Mark Levine and the Anti-Defamation League.Moves Myriad Genetics
Connections
The 10 strongest of 71, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Scott Gleason Structural
Scott Gleason was a senior executive at Myriad Genetics, leading corporate strategy and investor relations.
-
TD Cowen Operational
TD Cowen provides investment ratings and reports on Myriad Genetics stock.
-
Ben Wheeler Structural
Ben Wheeler served as the Chief Financial Officer of Myriad Genetics.
-
supreme court Transactional
A specific ruling by the Supreme Court impacted the operational status and market viability of Myriad Genetics.
-
Applied DNA Sciences Operational
Both companies are small-cap entities operating in the healthcare sector and are identified as competitors.
-
Carrie Wheeler Mentioned together
Carrie Wheeler provided financial commentary regarding Myriad Genetics' corporate results.
-
Fair Trade USA Structural
The companies are linked through shared board membership of Rashmi Kumar.
-
MarketBeat Mentioned together
MarketBeat provides financial tracking and target price reports for Myriad Genetics.
Show all 10 connections
-
sera Shared context
Both Myriad Genetics and sera operate within the diagnostics and life sciences sector.
-
New York City Shared context
Myriad Genetics operates as a company based in New York City and reports financial results there.
History
Events by the month they beganOctober 2026
2 eventsSeptember 2026
1 eventAugust 2026
2 eventsShow 2 earlier months
July 2026
2 eventsJune 2026
17 events- Several companies, including Guardant Health and Myriad Genetics, are competing in the liquid biopsy market.
- Ben Wheeler was promoted to Chief Financial Officer (CFO) at Myriad Genetics on August 18, 2025.
- Sera and Myriad Genetics are appointing a board of directors to guide the company, both operating in diagnostics and life sciences.
- Myriad Genetics and Palo Alto Networks are mentioned as high-flying stocks, and Nir Zuk is noted as the founder of Palo Alto Networks.
- Myriad Genetics received certification based on employee feedback.
- Major diagnostic companies, including Bio-Rad, Quest Diagnostics, and Myriad Genetics, are driving market growth.
- UnitedHealth Group reported poor earnings on July 30, 2025.
- UnitedHealth Group, Myriad Genetics, and NeoGenomics are involved in a situation concerning the cancer diagnostics space and weaknesses in the broader healthcare sector.
- Myriad Genetics, Biogen, Moderna, and Microsoft are discussed as peers in the therapeutics segment and are mentioned in thematic investing contexts.
- Myriad Genetics shares underperformed the market index on August 6, 2025, while operating in the biomedical and genetics industry and tracking earnings estimate revisions.
- Greg Abram, who previously held leadership roles at Myriad Genetics, was welcomed to the RxPreferred Benefits team along with Keith, announced in Nashville on August 12, 2025.
- Sam Raha highlighted operational execution and workflow improvements at Myriad Genetics on August 13, 2025.
- TD Cowen analyst inquired about growth contributions regarding Myriad Genetics.
- Personal health and wellness is identified as a secular tailwind for the industry.
- Angle and Myriad Genetics are collaborating, with Angle providing CTCs from tissue tests for Myriad's molecular analysis, aiming to extend to blood samples.
- Bio-Techne and Myriad Genetics are identified as key players in the biomarkers industry, while the American Cancer Society provides prostate cancer prevalence statistics.
- Myriad's MRD test was studied by Chad Tang.